In the current study the ex vivo permeation of ropinirole hydrochloride (RH) across porcine buccal mucosa in the presence of three permeation enhancers namely; Ntrimethyl chitosan (TMC) (positively charged) a chitosan derivative, sulfobutyl ether-β-cyclodextrin (SBE-β-CD) (negatively charged) and hydroxypropyl-β-cyclodextrin (HP-β-CD) (neutral), was investigated. Buccal permeation studies were conducted using Franz diffusion cells. Cumulative amounts of RH were plotted versus time. The presence of the permeation enhancers significantly increased the transport of the drug across the porcine buccal epithelium compared to its plain congener (RH solution). The rank order effect of the permeation enhancers for the transport of RH across buccal epithelium was TMC ≥ SBE-β-CD > HP-β-CD > RH solution. The presence of TMC increased 1.34 fold the transport of RH across buccal epithelium whereas an increase of 1.23 and 1.28 fold was reported in the presence of HP-β-CD and SBE-β-CD. Infrared spectroscopy (IR) was employed to investigate the interaction of permeation enhancers with the epithelial lipids of porcine buccal mucosa corroborating the permeation results.
The buccal route offers many advantages over conventional routes of drug delivery with an improved bioavailability at smaller doses than oral formulations due to the avoidance of degradation in the gastrointestinal tract and hepatic first-pass metabolism [1] . Drugs can reach the systemic circulation directly through the capillary vessels, bypassing the first-pass metabolism in the intestine and liver or avoiding inactivation in the stomach.
These characteristics contribute to higher bioavailability parameters after administration of a smaller dose of the drug than in conventional oral formulations [2] .
An approach to overcome the barrier properties of the buccal mucosa for drugs is the incorporation of chemical enhancers in the formulations [3, 4] . Bile salts, cyclodextrins and chitosan are commonly used enhancers. Methyl-β-and β-cyclodextrins have been previously evaluated for their potential enhancement effect on the buccal permeation of omeprazole [5] . Chitosan [6] and its derivatives [7, 8] have also showed a significant enhancing effect on permeation of drugs across the buccal mucosa.
In an attempt to investigate the effect of charge to the transport rate of ropinirole hydrochloride (RH) and any effect at the ultrastructure of the tissue three permeation enhancers, namely N-trimethyl chitosan (positively charged) a chitosan derivative, sulfobutyl ether-β-cyclodextrin (SBE-β-CD) (negatively charged) and hydroxypropyl-β-cyclodextrin (HP-β-CD) (neutral) were investigated. RH is a dopamine non-ergoline agonist for Parkinson's disease therapy undergoing extensive first-pass metabolism; therefore might be a good candidate for buccal administration [9] [10] [11] [12] .
Porcine buccal mucosa, being a non-keratinized epithelium and strongly supplied with blood by a dense capillary vessel network, has been used as model membrane because its morphology and permeability are comparable to that of human buccal epithelium [13, 14] . Buccal permeation studies were conducted using Franz diffusion cells.
Infrared spectroscopy (IR) was employed to investigate the interaction of permeation 4 enhancers with the epithelial lipids of porcine buccal mucosa. Finally light microscopy was performed to assess the histological changes resulting from the presence of the permeation enhancers.
Materials and methods

Materials
Ropinirole HCl was kindly supplied by Pharmathen SA, Greece. Sulfobutyl ether-β-cyclodextrin (SBE-β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) KLEPTOSE ® were purchased from Roquette (Lestrem, France) Captisol ® (La Jolla, USA) with MW 2170 and 1400 g/mol respectively. Methanol (MeOH) was purchased from Chem-Lab NV (Belgium) and CH3COONH4 (MW 77.08) from Panreac Quimica SA (Spain).
Buffer pH 6.8 solution simulating saliva was prepared using NaCl (0.85 g), Na2HPO4
(0.20 g) and NaH2PO4. 2H2O (0.13 g) in 100 mL of distilled water. Phosphate buffered saline (PBS) pH 7.4, was prepared by dissolving NaCl (8.0g), KCl (0.20 g), Na2HPO4
(1.44 g), and KH2PO4 (0.24 g) in 1L of distilled water. Low molecular weight (LMW, 150 kDa, DD 95 -98 %) chitosan was obtained from Fluka UK. Methyl iodide and 1-methyl-2-pyrrolidinone were obtained from Across Organics, Belgium. All chemicals and solvents were of analytical grade and all components of buffer solutions were purchased from Merck (Germany).
Trimethylchitosan synthesis and characterisation
Chitosan polymer were reductively methylated to form TMC polymers with low degree of quaternisation according to the method of Sieval et al. [15] . Briefly chitosan (2.0 g) and sodium iodide (4.8 g) were dissolved in N-methyl-2-pyrrolidinone (80 mL) on a water bath at 60 °C under stirring. Sodium hydroxide (11 mL, 15 % w/v) and methyl iodide (11.5 mL) were added when the chitosan was fully dissolved and the reaction was left stirring for 1 h at 60 °C in the presence of a Liebig condenser. The polymer products were then collected by precipitation with ethanol and ether and isolated by centrifugation using a Jouan B4i centrifuge (Thermo Electron Corporation, Waltham, USA). The products were washed twice with ethanol and diethyl ether to yield Ntrimethylchitosan iodide with a low degree of quaternisation. Ion exchange was undertaken by dissolving the product in sodium chloride (40 mL, 10 % w/v).
The product was again precipitated with ethanol and diethyl ether and isolated by centrifugation to yield a white powder, which was subsequently dissolved in deionized water (40 mL) and filtered using a dialysis membrane to remove any residual sodium 
Tissue preparation and transport studies
Fresh porcine mucosal specimens were obtained from a local slaughterhouse. After killing the animals, the tissue was immediately removed and transported to the laboratory in ice-cold buffer (PBS). The lag time between tissue isolation and start of the experiment was approximately 30 min. The specimens were surgically treated, using scalpel and scissors, to remove excesses of connective and adipose tissue. The thickness of the tissues was measured using a micrometer and the thickness of slices ranged from 650 to 800 μm. 
Sample analysis
Upon their collection the samples were centrifuged for 10 minutes at 12,000 rpm, the 
Analysis of permeation data
The steady state flux (Js) across the epithelium were calculated using the following
equation,
Js= Q/A t (μg/cm 2 hr) (1) where Q is the cumulative amount of drug penetrating the mucosa (μg), A is the diffusional area (cm 2 ) and t is the total time of the experiment (h).
The permeability coefficient (P) was then calculated according to the following
where Cd is the drug concentration in the donor compartment.
In order to normalize the permeability data in the presence of the enhancer compared to control, enhancement ratios (ER) were calculated according to equation (3),
where Penh is the permeability coefficient corresponding to the enhancer treated epithelial tissues, and Pcontrol is the permeability coefficient respectively for the control (RH solution).
Infrared Spectroscopy
Infrared spectroscopy (IR) was employed to investigate the interaction of permeation enhancers with the epithelial lipids of porcine buccal mucosa. At the end of each 8 experiment, pieces of tissue were soaked in PBS for ca. 10 sec to rinse the enhancers from the mucosal surface and then placed in a dessicator for drying. Intact (untreated) buccal tissue epithelium was used as the control. Analysis of the samples was carried using a spectrophotometer ATR-FTIR (Prestige-21, SHIMADZU) in the range between 4000 and 650 cm-1 with a resolution of 4 cm -1 after 64 scans.
Histological evaluation
Abnormalities of the mucosal architecture after drug and chemical enhancers and nontreated buccal epithelium, were evaluated using 4 μm-thick sections of each of the formalin-fixed and paraffin-embedded samples stained by conventional hematoxylineosin. Specimens were analysed in an Olympus CX31 optical microscope and microphotographs were taken via the OLYMPUS analysis getIT software.
Statistical analysis
The results are presented as mean ± standard deviation of 6 experiments. Statistical differences were tested using unpaired Student t-test (p<0.05).
Results and Discussion
Determination of degree of quartenisation
The degree of quaternisation of TMC polymer from the 1H-NMR spectrum ( Figure 1) was calculated from Eq. 4,
DQ (%) = [(TM/H) x 1/9] x 100 (4)
where DQ (%) is the degree of quaternisation expressed as a percentage, TM is the integral of the trimethyl amino group (N(CH3)3) peak at 3.3 ppm and H is the integral of the 1 H peaks between 4.7 and 5.7 ppm. From Eq.1 the degree of quaternisation of 9 chitosan was calculated at 17-18 % which is in broad agreement with previous studies [16] .
Transport studies
Permeation profiles of plain drug and its permeation enhancement congeners, expressed as the cumulative amount permeated versus time, are shown in Figure 2 . The steady state flux (Js) across the epithelium, the permeability coefficient (P) and the enhancement ratios are illustrated at Table 1 In a previous study the enhancing properties of TMC for the buccal delivery of a model macromolecular permeate (FITC-Dextran 4.4 kDa) have been attributed to partial dismantling of the structure of the extracellular matrix and intercellular joints which in turn weakens the epithelium barrier [7] . The enhanced ratios compared to the control in the presence of the cyclodextrins could be attributed to the fact that these oligosaccharides can permeate biomembranes, interacting with the lipids and increasing drug uptake through the epithelium [17, 18] .
Infrared spectroscopy analysis
Although buccal mucosa represents a non-cornified epithelia, these typical CH2 bands have already been reported for buccal mucosa in FTIR spectra [4, 19] . Of particular interest are the peaks near 2854 and 2918 cm -1 ( Figure 3A ). After treatment with the enhancers, stretching vibrations were broadened but no significant shift was observed.
The areas under the CH2 symmetric and asymmetric stretching absorbance were calculated as illustrated in Figure 3B . When the tissue was treated with RH and neutral HP-β-CD a decrease to the areas of the symmetric and asymmetric peak were observed compared to the control. However striking differences compared to untreated tissue were recorded in the presence of negatively charged SBE-β-CD and positively charged TMC where these peaks vanish implying alterations to epithelial lipid structure and organization. The enhancing action of TMC of SBE-β-CD for the transport of RH might be related with possible solubilization of intercellular lipids.
Histopathology data
Light microscopy was performed to assess the histological changes resulting from the presence of the permeation enhancers. In the histological analysis tissue specimens were treated with plain RH, RH/TMC, RH/SBE-β-CD and RH/HP-β-CD and were compared to normal oral porcine non-keratinized buccal mucosa. Specimens were analysed in an optical microscope (Olympus CX31). When comparing the normal buccal non-keratinized epithelium ( Figure 4A ) with the RH treated tissue, epithelial disarray, gap formation as well as moderate detachment of the total epithelium could be identified for the latter ( Figure 4B ). In contrast, buccal non-keratinized epithelium after 5h treatment with RH and TMC revealed an increase of epithelium thickness, epithelial detachment and mild acantholytic alterations (gaps) ( Figure 4C ). Previous studies have shown that an increase in intercellular space and swelling is related with increased permeation rates of the active [4] . [20] . However it should be noticed that although the presence of the permeation enhancers induce changes to the ultrastructure of buccal epithelium, the latter are not irreversible.
Conclusions
The data from the current study demonstrate that the transport of RH across buccal epithelium is substantially increased by co-administration of permeation enhancers.
The highest fluxes observed in the presence of the positively charged enhancer TMC combined with the minor structural changes to the epithelium, may be a promising approach to increase RH through buccal mucosa using different dosage forms (e.g.
films, xerogels) [21, 22] . Considering that buccal epithelium is permselective [23] , with proper manipulation of the membrane, favorable conditions might be created for the transport of charged drugs (e.g. morphine sulfate, atenolol hydrochloride) 
